NPI registry status
Active
2026 NPPES data Nephrology Physician NPI 1811085749 M.D.
Verify on CMS → Ellery Canlas, M.D.
Nephrology Physician in Merritt Island, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,806 in Nephrology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 279 beneficiaries · Nephrology Physician avg: 2K
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$338.41
16 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Ellery Canlas, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,819 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 2K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥83rd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Ellery Canlas, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1811085749), first enumerated 10/10/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,819 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$338.41 in reported industry payments (16 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Ellery Canlas, M.D.'s individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1811085749 · Nephrology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1811085749
- ENUM-LEGACY 2006
- TAX-MID 11K Nephrology Physician
- MIPS-NEUTRAL 75/100
- RX-MID 1,819
- BOOK-LIGHT 687 in Florida
- PHOTO-ENUM Alfred Cheung · 2006
Ellery Canlas, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,819 ≥ 83rd percentile 83% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Ellery Canlas, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ellery Canlas, M.D.?
CMS neutral score, not measuredPrimary specialty
Nephrology Physician
Medicare Part D claims
1,819 20% vs specialty avg
MIPS final score
75/100
Specialty distribution in Florida
How Nephrology Physician compares to other specialties among Florida providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1811085749 |
|---|---|
| Specialty | Nephrology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/10/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Hospital and facility affiliations
Facilities where Ellery Canlas, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Brevard Nephrology Group PA
Merritt Island, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ellery Canlas, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$338
Largest payer
Bayer Healthcare Pharmaceuticals Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Ellery Canlas, M.D.. To verify Ellery Canlas, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,819
Total Claims
$370K
Total Drug Cost
279
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,340
- Total Day Supply
- 128,231
- Generic Drug Cost
- $74K
- Antibiotic Claims
- 52
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 3.53
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 41, 65-74: 91, 75-84: 101, 85+: 46
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Ellery Canlas, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Losartan Potassium
Losartan Potassium
143 claims
- Calcitriol
Calcitriol
122 claims
- Furosemide
Furosemide
121 claims
- Amlodipine Besylate
Amlodipine Besylate
99 claims
- Allopurinol
Allopurinol
81 claims
- Farxiga
Farxiga
63 claims
- Hydralazine Hcl 55
Hydralazine Hcl
55 claims
- Spironolactone 44
Spironolactone
44 claims
| Drug | Claims |
|---|---|
| Losartan Potassium | 143 |
| Calcitriol | 122 |
| Furosemide | 121 |
| Amlodipine Besylate | 99 |
| Allopurinol | 81 |
| Farxiga Dapagliflozin Propanediol | 63 |
| Hydralazine Hcl | 55 |
| Spironolactone | 44 |
| Calcium Acetate | 42 |
| Tamsulosin Hcl | 42 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nephrology Physician Overview
How Ellery Canlas, M.D. fits within the Nephrology Physician landscape nationally.
10,806
Nephrology Physician Providers in US
55
States with Nephrology Physician
1,511
Avg Claims per Provider
Ellery Canlas, M.D.'s 1,819 claims are above the specialty average of 1,511.
Nationwide Nephrology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Canlas, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Nephrology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Canlas.
One of 687 Nephrology Physician providers enrolled in Florida, 5 are shown here.
Dr. Fernando Abanilla
MD
Avon Park, FL
Fakhar Abbas
Plantation, FL
Dr. Lionel Abbott
MD
Orlando, FL
Dr. Beshoy Abdalla
DO
Tampa, FL
Dr. Layal Abdel Rahman
M.D.
Largo, FL
Compare Nephrology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ellery Canlas, M.D.'s specialty? ▼
Ellery Canlas, M.D. specializes in Nephrology Physician and practices in Merritt Island, Florida. Credentials: M.D..
How much does Ellery Canlas, M.D. prescribe under Medicare Part D? ▼
In 2024, Ellery Canlas, M.D. wrote 1,819 Medicare Part D claims totaling $370K in drug costs for 279 beneficiaries.
What is Ellery Canlas, M.D.'s Medicare quality score? ▼
Ellery Canlas, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Ellery Canlas, M.D. located? ▼
Ellery Canlas, M.D. is located at 245 S COURTENAY PKWY, Merritt Island, FL, 32952. Phone: (321) 453-5326.
What is Ellery Canlas, M.D.'s NPI number? ▼
Ellery Canlas, M.D.'s National Provider Identifier (NPI) is 1811085749, issued on 10/10/2006.
How many Nephrology Physician providers are there in the US? ▼
There are 10,806 Nephrology Physician providers across 55 states in the US. The average Nephrology Physician provider writes 1,511 Medicare Part D claims per year.
What drugs does Ellery Canlas, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Ellery Canlas, M.D.'s most frequently prescribed drugs include Losartan Potassium, Calcitriol, Furosemide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ellery Canlas, M.D. accept Medicare? ▼
Ellery Canlas, M.D. appears in CMS Medicare data with 1,819 Part D claims and 279 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ellery Canlas, M.D.'s credentials? ▼
Ellery Canlas, M.D.'s NPI is 1811085749 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.